An Electronic Brief Alcohol Intervention for Women Attending a Breast Screening Service (Health4Her)

NCT06019442 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2024-02-09

No results posted yet for this study

Summary

Alcohol is a major modifiable risk factor for female breast cancer; yet, awareness of this risk remains surprisingly low and is not systematically addressed in healthcare settings. This study aim to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.

Conditions

  • Health Knowledge, Attitudes, Practice
  • Alcohol Drinking

Interventions

BEHAVIORAL

Brief alcohol intervention (Health4Her-Automated)

Embedded within the lifestyle health promotion provided in both conditions, participants randomised to the experimental condition will receive a brief alcohol intervention. The brief alcohol intervention will comprise information and behaviour-change content regarding alcohol consumption, including: messaging around alcohol risks/harms (with a focus on alcohol use and breast cancer risk), positive-framed messaging on the health benefits of reducing alcohol intake, and alcohol harm-reduction / behaviour change strategies (e.g. drink counting, goal setting, behaviour substitution, problem solving). Post-session information will be provided via email (i.e. electronic brochure summarising brief alcohol intervention content).

BEHAVIORAL

Lifestyle health promotion

Lifestyle health promotion, focused on physical activity and maintaining a healthy weight for reducing breast cancer risk, will be provided. Post-session information will be provided via email (i.e. electronic brochure summarising nutrition for maintaining a healthy weight).

Sponsors & Collaborators

  • Monash University

    collaborator OTHER
  • Eastern Health

    collaborator OTHER
  • BreastScreen Victoria

    collaborator UNKNOWN
  • Lifepool

    collaborator UNKNOWN
  • Shades of Pink

    collaborator UNKNOWN
  • Turning Point

    lead OTHER

Principal Investigators

  • Jasmin Grigg, PhD · Turning Point, Eastern Health; Monash University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-10-06
Completion
2023-12-01

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06019442 on ClinicalTrials.gov